Hi guys, I'm an optometrist and in my opinion iTrack is overhyped atm. There are many MIGS devices in the market with the most popular one being iStent - produced by Glaukos. The problem with iTrack is the surgery being more complicated and technically challenging which I fear will deter eye surgeon from using. The biggest potential imo is actually the 2RT. There is currently no treatment for dry AMD, so I'm hoping the 2018 study shows good results for 2RT and that's where I believe the bulk of the future revenue with come from.
Cheers
Ann: Ellex Sales Trading Update, page-17
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65104 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 51773 | 2 |
View Market Depth
| Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |